Literature DB >> 17174185

Ischemia-modified albumin in relation to exercise stress testing.

Eftihia Sbarouni1, Panagiota Georgiadou, George N Theodorakis, Dimitrios Th Kremastinos.   

Abstract

OBJECTIVES: We examined whether ischemia-modified albumin (IMA) plasma levels change during exercise stress testing (EST) in patients with known coronary artery disease and whether the induced changes differ between positive and negative exercise tests.
BACKGROUND: Ischemia modified albumin is considered a marker of myocardial ischemia and increases after coronary angioplasty and in acute coronary syndromes.
METHODS: We studied 40 consecutive patients with established coronary artery disease who underwent EST. Venous samples, for IMA measurement, were collected before the stress test (baseline), at peak exercise, and 60 min after the completion of the exercise test.
RESULTS: There was significant difference in the IMA values at the 3 prespecified time points (p = 0.012), whereas there was no interaction between the IMA changes and the result of the stress test, whether positive or negative (p for the interaction term = 0.94). Baseline, peak EST, and post-EST IMA levels were similar in patients with positive and negative exercise tests (p = 0.61). The IMA significantly decreased at peak exercise compared with baseline values in positive (p < 0.0001) and in negative EST (p = 0.012). Moreover, IMA concentration increased 60 min after EST compared with peak-EST values in positive (p < 0.0001) and in negative tests (p = 0.003), returning to pre-EST levels in both groups.
CONCLUSIONS: The IMA plasma levels change significantly during exercise testing in patients with coronary artery disease, but there is no difference between positive and negative stress tests; this possibly implies that the observed changes do not reflect myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174185     DOI: 10.1016/j.jacc.2006.06.007

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Endothelial Dysfunction and Ischemia-Modified Albumin Levels in Males with Diabetic and Nondiabetic Erectile Dysfunction.

Authors:  Hasan Anıl Kurt; Emrah Demirci; Cabir Alan
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

2.  Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

Authors:  Luiz Carlos Cichota; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; José Edson Paz da Silva
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Ischaemia modified albumin: Does it bolster our diagnostic ammunition?

Authors:  Dilip Gude; Ramesh Babu Byrapaneni
Journal:  Indian J Anaesth       Date:  2011-07

4.  Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients.

Authors:  Guifang Yang; Yang Zhou; Huaping He; Xiaogao Pan; Xiangping Chai
Journal:  Front Physiol       Date:  2019-09-27       Impact factor: 4.566

5.  Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests.

Authors:  June Hong Kim; Jae Hoon Choi; Hyun-Kook Lee; Woo Hyung Bae; Kook-Jin Chun; Yun Seong Kim; Sang Kwon Lee; Hyung Hoi Kim; Taek Jong Hong; Yong Woo Shin
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 3.165

6.  The effects of spinal, inhalation, and total intravenous anesthetic techniques on ischemia-reperfusion injury in arthroscopic knee surgery.

Authors:  Müge Koşucu; Ilker Coşkun; Ahmet Eroglu; Dilek Kutanis; Ahmet Menteşe; S Caner Karahan; Emre Baki; Servet Kerimoğlu; Murat Topbas
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.